Laura Cámpora

3.1k total citations · 1 hit paper
12 papers, 659 citations indexed

About

Laura Cámpora is a scholar working on Epidemiology, Dermatology and Infectious Diseases. According to data from OpenAlex, Laura Cámpora has authored 12 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 4 papers in Dermatology and 3 papers in Infectious Diseases. Recurrent topics in Laura Cámpora's work include Herpesvirus Infections and Treatments (8 papers), Acne and Rosacea Treatments and Effects (4 papers) and Bartonella species infections research (2 papers). Laura Cámpora is often cited by papers focused on Herpesvirus Infections and Treatments (8 papers), Acne and Rosacea Treatments and Effects (4 papers) and Bartonella species infections research (2 papers). Laura Cámpora collaborates with scholars based in Belgium, United States and Spain. Laura Cámpora's co-authors include Thomas C. Heineman, Himal Lal, Laurence Fissette, Lusiné Kostanyan, Isabel Leroux‐Roels, Tino F. Schwarz, Nathalie De Schrevel, Nancy Dezutter, Joanne M. Langley and Richard N. van Zyl-Smit and has published in prestigious journals such as New England Journal of Medicine, The Journal of Infectious Diseases and The Journals of Gerontology Series A.

In The Last Decade

Laura Cámpora

12 papers receiving 625 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults

2023 405 citations Alberto Papi, Michael G. Ison et al. New England Journal of Medicine profile →

Peers

Laura Cámpora

EPIDE

PRM

PARAS

DERMA

Mary Rinki United States

Abeer Moanna United States

Heinz J. Schmitt Germany

Schmid Switzerland

S. Pinchinat France

Ziad M. Shehab United States

Randy Bergen United States

J Rush United States

Heidi Smuts South Africa

Matthew Donati United Kingdom

Mary Rinki United States

Laura Cámpora

654 ×1.1

EPIDE

181 ×1.0

25 ×0.2

PRM

38 ×0.4

PARAS

20 ×0.3

DERMA

Citations per year, relative to Laura Cámpora Laura Cámpora (= 1×) peers Mary Rinki

Countries citing papers authored by Laura Cámpora

Since Specialization

Citations

This map shows the geographic impact of Laura Cámpora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Cámpora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Cámpora more than expected).

Fields of papers citing papers by Laura Cámpora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Cámpora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Cámpora. The network helps show where Laura Cámpora may publish in the future.

Co-authorship network of co-authors of Laura Cámpora

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Cámpora. A scholar is included among the top collaborators of Laura Cámpora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Cámpora. Laura Cámpora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Papi, Alberto, Michael G. Ison, Joanne M. Langley, et al.. (2023). Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults. New England Journal of Medicine. 388(7). 595–608. 405 indexed citations breakdown →

Ceregido, Maria Angeles, et al.. (2022). Fourteen years of the Pregnancy Registry on maternal immunisation with a reduced-antigen-content tetanus-diphtheria-acellular pertussis (Tdap) vaccine. Vaccine. 40(6). 904–911. 4 indexed citations

Meyer, Nadia, et al.. (2020). Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study. Human Vaccines & Immunotherapeutics. 17(3). 723–730. 3 indexed citations

Strezova, Ana, Himal Lal, Laura Cámpora, et al.. (2019). The adjuvanted recombinant zoster vaccine co-administered with a tetanus, diphtheria and pertussis vaccine in adults aged ≥50 years: A randomized trial. Vaccine. 37(39). 5877–5885. 21 indexed citations

Kovac, Martina, Himal Lal, Anthony L. Cunningham, et al.. (2018). Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials. Vaccine. 36(12). 1537–1541. 34 indexed citations

Curran, Desmond, Lidia Oostvogels, Thomas C. Heineman, et al.. (2018). Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older. The Journals of Gerontology Series A. 74(8). 1231–1238. 43 indexed citations

Lal, Himal, Airi Põder, Laura Cámpora, et al.. (2017). Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study. Vaccine. 36(1). 148–154. 44 indexed citations

Cámpora, Laura, Martine Douha, Thomas C. Heineman, et al.. (2017). Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine. The Journal of Infectious Diseases. 216(11). 1343–1351. 52 indexed citations

López‐Fauqued, Marta, Laura Cámpora, Mohamed El Idrissi, et al.. (2017). Results of a Safety Pooled Analysis of an Adjuvanted Herpes Zoster Subunit Vaccine in More than 14,500 Participants Aged 50 Years or Older. Open Forum Infectious Diseases. 4(suppl_1). S416–S416. 1 indexed citations

10.

Cámpora, Laura, Martine Douha, Thomas C. Heineman, et al.. (2017). Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: A Phase III, Group-Matched, Clinical Trial. Open Forum Infectious Diseases. 4(suppl_1). S414–S414. 4 indexed citations

11.

Godeaux, Olivier, Martina Kovac, Daniel Shu, et al.. (2017). Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial. Human Vaccines & Immunotherapeutics. 13(5). 1051–1058. 45 indexed citations

12.

Cámpora, Laura, A. Valiente, Marcela Castillo, et al.. (2008). Búsqueda de afecciones genéticas como etiología de déficit intelectual en individuos que asisten a escuelas de educación especial. Revista médica de Chile. 136(12). 1542–51. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact